Spot-on, tablet, or Collar – if you want to use chemical tick protection, you are faced with a choice that at first glance seems to compare only brand names. From a professional perspective, however, the decisive factors are not the product names, but active substance classes, routes of application, and risk profiles. In this article, we therefore go one level deeper than in the general tick protection guide and look at what truly distinguishes the three major groups of preparations – and why the same substance may be suitable for one dog and unsuitable for another.
This text does not replace veterinary advice. It is intended to help dog owners make a well-founded decision together with their veterinarian, rather than relying on the loudest argument in comment sections.
Three modes of action: How spot-ons, tablets, and Collars fundamentally differ
Chemical tick protection is not a single mechanism, but a family of very different approaches. In simplified terms, three main classes can be distinguished:
- Spot-on preparations are applied locally to the skin between the shoulder blades. The active substances spread through the skin’s sebum layer and have partly repellent effects, partly direct killing effects.
- Tablets are given orally and act systemically. The tick must first bite, takes up the active substance through the blood, and then dies.
- Collars continuously release active substances to the skin and the skin’s lipids over weeks to months, and often combine a killing active substance with a repellent one.
These differences are not just technical details. They determine whether a tick can attach at all, how quickly it dies – and which side effects are relevant for which dog.
Repellent or killing – an important difference
Repellent active substances are intended to prevent the tick from biting in the first place. Pure acaricides, on the other hand, kill the tick only after it has bitten. This matters because many pathogens – such as Borrelia burgdorferi in Lyme borreliosis – are not transmitted immediately at the time of the bite, but only after several hours of feeding. With anaplasmosis or ehrlichiosis, transmission can occur much more quickly. Depending on the pathogen and region, it is therefore not irrelevant whether a product repels the tick or only kills it.
Spot-ons in detail: Permethrin, fipronil, and combinations
Spot-ons are probably the best-known form of chemical tick protection. They are not all the same – the active substance groups differ significantly both in how they work and in their risk profile.
Permethrin – effective, but toxic to cats
Permethrin belongs to the pyrethroids and has both repellent and tick-killing effects. It is one of the few active substances with a notable “anti-feeding effect,” meaning that many ticks do not bite in the first place. In studies related to travel medicine – for example protection against Mediterranean sand flies that transmit Leishmania – permethrin in combination with other pyrethroids is among the best-documented active substances (ESCCAP recommendations).
What matters, however, is this: Permethrin is highly toxic to cats. Cats can hardly break down the active substance via their liver, and even skin contact with a freshly treated dog can lead to severe neurological symptoms and even death. In multi-pet households with cats, permethrin is therefore simply not practical in the vast majority of situations.
Fipronil and combination preparations
Fipronil primarily has a killing effect and is not mainly repellent. It has been established for decades and is comparatively well tolerated. However, there are indications of increasing regional resistance development in fleas, which is why some preparations combine fipronil with additional active substances such as (S)-methoprene (an insect growth regulator).
Practical pitfalls with spot-ons
Spot-ons only work if they distribute correctly. Frequent bathing, swimming, or harsh shampooing shortly before or after application can significantly shorten the duration of effect. Too low a dose due to underestimated body weight, or dividing a large-dog dose among several small dogs (“splitting”), also regularly leads to reduced efficacy.
Isoxazoline tablets: High efficacy – and the 2018 FDA warning
Probably the biggest change in tick protection over the past ten years has been the isoxazolines: fluralaner (e.g. in Bravecto), afoxolaner, sarolaner, and lotilaner. They are usually given as chewable tablets and act systemically through the dog’s blood.
Important to understand: isoxazolines are not repellents. The tick must bite in order to die. For pathogens that are transmitted quickly, a residual risk therefore remains – but rapid killing reduces it considerably.
FDA warning 2018: Seizures and neurological symptoms
The European Medicines Agency (EMA) and its pharmacovigilance committee PRAC also regularly reassess isoxazolines. In European product information, neurological side effects are now explicitly listed as rare possible reactions. The approvals remain in place because the benefit-risk ratio is considered favorable for the overall population – but in individual cases, this does not remove the need for a differentiated decision.
What this means in practice
For many dogs, isoxazolines are a highly effective, well-tolerated tool. For dogs with known epilepsy or neurological pre-existing conditions, we take a more nuanced view: from our perspective, it is essential to discuss the topic openly with the treating veterinarian rather than reflexively using the preparation or reflexively rejecting it. At Vito and Amalia, we also regularly point out in consultations that, even without a known history, the dog should be observed closely after the first dose – not out of distrust, but as a normal duty of care.
Collars: Long-term effect using imidacloprid + flumethrin as an example
Tick Collars with a medicinal active substance should not be confused with decorative Collars containing essential oils. The preparation in this class most commonly used in veterinary practice combines imidacloprid and flumethrin (brand name Seresto, EMA-approved). The active substances are released continuously onto the skin and coat over several months and have both killing effects and, to a certain extent, repellent effects.
Benefits – and what to pay attention to
The practical advantage is the long duration of effect of up to around eight months, which makes compliance easier. Especially for dogs that do not take tablets well or where spot-ons are regularly forgotten, this can be a relevant factor. The EMA has reassessed the preparation as part of repeated reviews. The official result: there was no evidence of a previously unknown risk that would justify suspending the approval. At the same time, the product information was updated to specify application recommendations and possible adverse reactions more precisely.
When Collars are particularly useful – and when they are less suitable
Collars can be useful above all when long, continuous protection is desired – for example in regions with high year-round tick exposure or for dogs that frequently come into contact with wild meadows, forests, and undergrowth. They are generally less suitable if dogs spend a lot of time in water, if there is frequent close skin contact with small children who touch the Collar intensively, or if a dog generally does not accept Collars well.
Selection criteria: Which class suits which dog?
The most interesting question is rarely “What is the best product?” but rather “What is the most suitable product for this dog in this everyday life?” In consultation, we typically look at six areas:
- Health status: Are there pre-existing conditions, especially neurological ones (epilepsy, idiopathic seizures), liver or kidney dysfunction, severe skin allergies? This significantly changes the selection.
- Age and weight: Many preparations are not approved for very young puppies, nor for very low or very high body weight outside the dosing schedules.
- Region and season: Travel to Mediterranean countries with an increased risk of leishmaniasis, ehrlichiosis, or babesiosis changes the requirements – here, the “repellent component” becomes more important.
- Activity profile: City dog, forest dog, working hunting dog, or dog with a lot of water contact – this influences duration of effect, water resistance, and the usefulness of individual application forms.
- Multi-pet household: Cats in the household practically rule out permethrin. Small children change the assessment of Collars or spot-ons in the first hours after application.
- Compliance: Answered realistically: Does the dog reliably receive a tablet on schedule? Is a spot-on really reapplied on time?
How we handle this in consultation
Vito and Amalia do not make blanket recommendations. For a young, healthy city dog with manageable tick exposure, a sensible strategy often looks different than for a dog traveling to the Mediterranean or a dog with a history of seizures. What we do consistently recommend is this: make the decision together with your veterinarian, actively observe tolerability after the first application, and reassess the chosen product annually rather than simply continuing it for years.
Our Vitomalia conclusion
Spot-on, tablet, and Collar are not competitors in a “better or worse” logic, but three different tools with clear strengths and clear weaknesses. Spot-ons with a repellent component are particularly valuable when tick attachment is to be prevented – but they require special caution in multi-pet households with cats. Isoxazoline tablets are highly effective and practical, but must be weighed especially carefully in dogs with neurological predispositions, as the FDA and EMA have clearly documented. Collars offer long-term protection and compliance advantages, but they are not a “put it on and forget it” product.
For us, what counts is therefore not the active substance class as such, but the fit: health status, region, season, household, tolerability. The best chemical tick protection is the one that suits the individual dog, is properly supported by veterinary care, and whose side-effect profile is observed in everyday life – not the one that sounds best in an advertisement or is defended the loudest in a discussion. From our perspective, this is precisely where professional dog ownership lies: neither in a blanket “chemicals are poison” nor in a careless “it works, so it’s fine,” but in an honest, individual benefit-risk assessment.
